This review describes the pathophysiological and histopathological rational
e for using the cardiac isoforms of troponin T and troponin I in congestive
heart failure (CHF). It also focuses on the potential clinical usefulness
of new generation highly sensitive and specific cardiac troponin assays wit
h respect to histological monitoring, risk stratification and therapeutic f
ollow-up of patients with CHF. The availability of more powerful analytical
tools for these highly specific markers of myocardial injury offers a uniq
ue opportunity to expand the field of their application and to explore new
disease processes. Because cardiac troponin T and cardiac troponin I provid
e useful clinical information unavailable through other diagnostic techniqu
es, they appear as promising biochemical markers in patients with CHF. (C)
1999 Elsevier Science B.V. All rights reserved.